These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23126005)

  • 1. [Toward a transatlantic collaboration for the development of a research perspective focused on immunomodulation in ARDS].
    Monsel A
    Ann Fr Anesth Reanim; 2012 Sep; 31(9):744-5. PubMed ID: 23126005
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cell therapy for acute respiratory distress syndrome: a promising future?
    Horie S; Masterson C; Devaney J; Laffey JG
    Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis.
    Lee FY; Chen KH; Wallace CG; Sung PH; Sheu JJ; Chung SY; Chen YL; Lu HI; Ko SF; Sun CK; Chiang HJ; Chang HW; Lee MS; Yip HK
    Oncotarget; 2017 Jul; 8(28):45626-45642. PubMed ID: 28484089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome.
    Antebi B; Mohammadipoor A; Batchinsky AI; Cancio LC
    J Trauma Acute Care Surg; 2018 Jan; 84(1):183-191. PubMed ID: 29019797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?
    Yadav H; Thompson BT; Gajic O
    Am J Respir Crit Care Med; 2017 Mar; 195(6):725-736. PubMed ID: 28040987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality is the only relevant outcome in ARDS: yes.
    Moss M
    Intensive Care Med; 2015 Jan; 41(1):141-3. PubMed ID: 25476981
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of CD8
    Li GG; Cao YH; Run Y; Xu RX; Zheng ZD
    Clin Exp Pharmacol Physiol; 2016 Dec; 43(12):1191-1198. PubMed ID: 27558304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung-protective mechanical ventilation strategies in ARDS.
    Lee WL; Detsky AS; Stewart TE
    Intensive Care Med; 2000 Aug; 26(8):1151-5. PubMed ID: 11030175
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesenchymal stem cells: a promising therapy for the acute respiratory distress syndrome.
    Cárdenes N; Cáceres E; Romagnoli M; Rojas M
    Respiration; 2013; 85(4):267-78. PubMed ID: 23428562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality is the only relevant outcome in ARDS: no.
    Kress JP
    Intensive Care Med; 2015 Jan; 41(1):144-6. PubMed ID: 25476982
    [No Abstract]   [Full Text] [Related]  

  • 11. Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.
    Johnson CL; Soeder Y; Dahlke MH
    Stem Cells Transl Med; 2017 Apr; 6(4):1141-1151. PubMed ID: 28186706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The International Collaboration to Improve Respiratory Health in Children (INCIRCLE) ERS Clinical Research Collaboration.
    Sly PD; Hantos Z;
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30545960
    [No Abstract]   [Full Text] [Related]  

  • 13. Society for Pediatric Research presidential address 2008: can pediatric research benefit from global warming?
    Dennery PA
    Pediatr Res; 2009 Jan; 65(1):123-5. PubMed ID: 18703993
    [No Abstract]   [Full Text] [Related]  

  • 14. [Report of the President, Society of Hungarian Oncologists, leaving office (2005-2007)].
    Oláh E
    Magy Onkol; 2008 Mar; 52(1):89-95. PubMed ID: 18403303
    [No Abstract]   [Full Text] [Related]  

  • 15. Society for Pediatric Research 2012 Presidential Address: SPR strategic plan priorities 2012.
    Furth SL
    Pediatr Res; 2012 Nov; 72(5):545-7. PubMed ID: 23190623
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell therapies for ARDS: a promising start.
    Weiss DJ
    Lancet Respir Med; 2015 Jan; 3(1):2-3. PubMed ID: 25529341
    [No Abstract]   [Full Text] [Related]  

  • 17. The International Societies for Investigative Dermatology: the realization of a vision for unity and collaboration in the advancement of investigative dermatology and cutaneous biology.
    Amagai M; Enk A; Hall RP
    J Invest Dermatol; 2014 May; 134(5):1181-1183. PubMed ID: 24732326
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS.
    Huppert LA; Liu KD; Matthay MA
    Transfusion; 2019 Feb; 59(S1):869-875. PubMed ID: 30383290
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-based therapies for the acute respiratory distress syndrome.
    Maron-Gutierrez T; Laffey JG; Pelosi P; Rocco PR
    Curr Opin Crit Care; 2014 Feb; 20(1):122-31. PubMed ID: 24300620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells.
    Antebi B; Walker KP; Mohammadipoor A; Rodriguez LA; Montgomery RK; Batchinsky AI; Cancio LC
    Stem Cell Res Ther; 2018 Sep; 9(1):251. PubMed ID: 30257702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.